Vitiligo is an autoimmune disease of the skin characterized by epidermal melanocyte loss
resulting in white patches, with an approximate prevalence of 0.5–2% worldwide. Several …

Although senescence was originally described as an in vitro acquired cellular characteristic,
it was recently recognized that senescence is physiologically and pathologically involved in …

Vitiligo is a common acquired pigmentary disorder that presents as progressive loss of
melanocytes from the skin. Epidermal melanocytes and keratinocytes are in close proximity …

Vitiligo (VIT) is caused by loss and degradation of functional epidermal melanocytes.
Studies have indicated that melanocyte destruction may be associated with an imbalance …

Vitiligo is a potentially serious condition characterized by loss of melanin and death of
melanocytes. To identify potential therapeutic targets for vitiligo, we conducted a microarray …

Vitiligo is an acquired skin disorder clinically characterized by the progressive appearance
of white maculae due to a loss of functioning epidermal melanocytes. Studies have shown …

Vitiligo is a hypomelanotic skin disease and considered to be of autoimmune origin due to
breaching of immunological self-tolerance, resulting in inappropriate immune responses …

Vitiligo is the most frequent disorder of acquired depigmentation, characterized by achromic
patches due to the loss of melanocytes. 1, 2 Its pathogenesis is not completely understood …

Multiple sclerosis (MS) is the main reason for disability caused by autoimmunity. However,
effective biomarkers for MS have not been identified. This study explored the molecular …

Background Vitiligo is a complex disease in which patchy depigmentation is the result of an
autoimmune-induced loss of melanocytes in affected regions. On the basis of a genome …